Group 1 - On September 16, Aojing Medical executed a block trade of 350,000 shares, with a transaction value of 9.8315 million yuan, accounting for 2.03% of the total transaction volume for that day [1] - The transaction price was 28.09 yuan, which represents a discount of 1.51% compared to the market closing price of 28.52 yuan [1]

Summary of Key Points Core Viewpoint - On September 15, 2025, Aojing Medical (688613) closed at 26.71 yuan, marking a 3.13% increase with a turnover rate of 9.04% and a trading volume of 123,800 shares, resulting in a transaction value of 336 million yuan [1]. Trading Information - On September 15, the net inflow of main funds was 16.1 million yuan, accounting for 4.79% of the total transaction value [1][3]. - Retail investors experienced a net outflow of 4.2 million yuan, representing 1.25% of the total transaction value [1]. - A significant block trade occurred on September 15, with institutional net purchases amounting to 9.2 million yuan [1][3]. Company Announcements - Aojing Medical held its second extraordinary general meeting of shareholders in 2025 on September 15, where the proposal to supplement the non-independent directors of the second board was approved [1][3]. - The meeting was convened by the company's board and took place at the Beijing Daxing Biomedical Industry Base, with a combination of on-site and online voting [1]. - A total of 48 shareholders and authorized agents attended the meeting, representing 21,634,885 shares with voting rights, which is 15.79% of the total share capital on the registration date [1].

本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 9 月 15 日 证券代码：688613 证券简称：奥精医疗 公告编号：2025-051 奥精医疗科技股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （二） 股东大会召开的地点：北京市大兴区庆丰西路 69 号 35 号楼 3 层 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 48 | | --- | --- | | 普通股股东人数 | 48 | | 2、出席会议的股东所持有的表决权数量 | 21,634,885 | | 普通股股东所持有表决权数量 | 21,634,885 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 15.7908 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 15.7908 | （四） ...

北京市中伦律师事务所 关于奥精医疗科技股份有限公司 2025 年第二次临时股东大会的 在本法律意见书中，本所律师仅对本次股东大会的召集、召开程序、出席本 次股东大会人员和召集人的资格、会议表决程序及表决结果是否符合《公司法》 《股东会规则》等相关法律、法规、规章、规范性文件及《公司章程》的规定发 表意见，并不对会议审议的议案内容以及该等议案所表述的事实或数据的真实性 及准确性发表意见。本所仅根据现行有效的中国法律问题发表意见，而未对有关 会计、审计和资产评估等非法律专业事项发表意见，亦未对非中国法律问题发表 意见。 本所同意将本法律意见书作为本次股东大会的公告材料，随同其他会议文件 一并报送有关机构并公告。本法律意见书仅供公司为本次股东大会之目的而使用， 未经本所书面同意，本法律意见书不得用于任何其他目的。 基于上述，本所律师按照律师行业公认的业务标准、道德规范和勤勉尽责的 精神，对公司所提供的相关文件和有关事实进行了核查和验证，现出具法律意见 如下： 致：奥精医疗科技股份有限公司 北京市中伦律师事务所（以下简称"本所"）接受奥精医疗科技股份有限公 司（以下简称"公司"）委托，指派律师见证公司 2025 年第 ...

Group 1 - A total of 67 stocks experienced block trading on September 15, with a total transaction value of 2.22 billion yuan [1] - The top three stocks by transaction value were Hangzhou Steel (2.5 billion yuan), Guangqi Technology (2.23 billion yuan), and Demingli (2.04 billion yuan) [1] - Among the stocks, 10 were traded at par, 4 at a premium, and 53 at a discount; Zhejiang Meida, SF Holding, and HNA Technology had the highest premium rates of 9.04%, 7.06%, and 1.35% respectively [1] Group 2 - The top stocks by institutional buying were Hangzhou Steel (250 million yuan), Jiangsu Leili (198 million yuan), and Haiguang Information (106 million yuan) [2] - Other notable institutional purchases included Caida Securities (63.6 million yuan), BGI (25 million yuan), and Ningde Times (20.9 million yuan) [2] Group 3 - The top stocks by institutional selling included Xinyi Technology (21 million yuan), Ningde Times (20.9 million yuan), and BYD (20.8 million yuan) [3]

Summary of Key Points Core Viewpoint - On September 15, Aojing Medical executed a block trade of 350,000 shares, amounting to a transaction value of 9.2085 million yuan, which represented 2.67% of the total trading volume for that day. The transaction price was 26.31 yuan, reflecting a discount of 1.5% compared to the market closing price of 26.71 yuan [1]. Group 1 - The block trade involved 350,000 shares of Aojing Medical, with a total transaction value of 9.2085 million yuan [1]. - The transaction price of 26.31 yuan was lower than the market closing price, indicating a discount of 1.5% [1]. - The trade accounted for 2.67% of the total trading volume on that day [1]. Group 2 - The trade was executed by an institutional investor through Huatai Securities [2]. - The transaction occurred on September 15, 2025, under the stock code 688613 [2]. - The trading volume and price details were specifically recorded, highlighting the institutional nature of the transaction [2].

Group 1 - The core stock price of Aojing Medical (688613) closed at 26.03 yuan on September 12, 2025, down 3.38% with a turnover rate of 5.63% and a trading volume of 77,200 shares, resulting in a transaction amount of 202 million yuan [1] Group 2 - On September 12, the net inflow of main funds was 2.0993 million yuan, accounting for 0.79% of the total transaction amount [2][3] - Retail investors had a net inflow of 1.4728 million yuan, representing 0.55% of the total transaction amount [2] - There was a net outflow of 3.5721 million yuan from speculative funds, which accounted for 1.34% of the total transaction amount [2] Group 3 - On the same day, Aojing Medical recorded one block trade with institutional net purchases amounting to 7.653 million yuan [2][3]

Group 1 - The core transaction on September 12 involved a block trade of 300,000 shares of Aojing Medical, with a transaction value of 7.653 million yuan, at a price of 25.51 yuan, which represents a discount of 1.51% compared to the closing price of the day [2][3] - Over the past three months, Aojing Medical has recorded a total of five block trades, amounting to a cumulative transaction value of 36.216 million yuan [3] - On the same day, Aojing Medical's closing price was 25.90 yuan, reflecting a decline of 3.86%, with a turnover rate of 7.44% and a total trading volume of 266 million yuan, indicating a net outflow of 2.4371 million yuan in main funds [3] Group 2 - The latest margin financing balance for Aojing Medical is 155 million yuan, which has increased by 5.6297 million yuan over the past five days, representing a growth rate of 3.77% [3]

Group 1 - The stock price of Aojing Medical (688613) closed at 26.94 yuan on September 11, 2025, with an increase of 5.98% [1] - The trading volume was 141,400 lots, resulting in a total transaction amount of 374 million yuan [1] Group 2 - On September 11, the net inflow of main funds was 34.11 million yuan, accounting for 9.11% of the total transaction amount [2][3] - Retail investors experienced a net outflow of 27.05 million yuan, representing 7.22% of the total transaction amount [2] - There was one block trade on September 11, with institutional net purchases amounting to 10.616 million yuan [2][3]

Group 1 - The core transaction on September 11 involved a block trade of 400,000 shares of Aojing Medical, with a transaction value of 10.616 million yuan, at a price of 26.54 yuan, which represents a discount of 1.48% compared to the closing price of the day [2][3] - Over the past three months, Aojing Medical has recorded a total of four block trades, amounting to a cumulative transaction value of 28.563 million yuan [3] - On the same day, Aojing Medical's closing price was 26.94 yuan, reflecting an increase of 5.98%, with a daily turnover rate of 10.32% and a total transaction volume of 374 million yuan, indicating a net inflow of main funds amounting to 25.5087 million yuan [3] Group 2 - In the last five days, Aojing Medical's stock has increased by 36.82%, with a total net inflow of funds reaching 23.6377 million yuan [3] - The latest margin financing balance for Aojing Medical stands at 178 million yuan, having increased by 25.9959 million yuan over the past five days, which is a growth rate of 17.13% [3]